SZSE Ticker: 002390

Guizhou Xinbang Pharmaceutical Co., Ltd.

贵州信邦制药股份有限公司

信邦制药

XINBANG PHAR.

Listing Date: 2010-04-16

Board: SME

Industry Classification: Manufacturing

Does the company have any items and products that extract the vines? Xinbang Pharmaceutical: The company currently has no related business_ Oriental Fortune Net

Does the company have any items and products that extract the vines? Xinbang Pharmaceutical: The company currently has no related business_ Oriental Fortune Net

Xinbang Pharmaceutical: The company currently does not have Qianjinteng alkali related business_Oriental Fortune Net

Good News Express: The National Standing Committee requires fiscal and monetary policies to be employment-oriented, central power generation companies will be allocated 50 billion yuan in renewable energy subsidies, Shenglong shares received a notification from Sichuan Ideal

Rumors of "false positives" once forced the stock price of Runda Medical to stop: regulatory intervention to investigate the differentiation of nucleic acid detection sector into new coronary pneumonia jqknews

The "false positive" rumors once forced the stock price of Runda to stop! Regulatory involvement in the investigation, the nucleic acid detection sector is differentiated – yqqlm

The son inherits the father's business! The son of the former chairman of Zhongqingbao takes office as the "post-90s" and "heirs" of the A-share market. Who else is there?

R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com

A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline

A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D

Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball

Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net

Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews

[News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN

The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline

[Express] SINBON Pharma Announces Annual Report CFi.CN

Xinbang Pharmaceutical (002390): Minsheng Securities Co., Ltd. on Guizhou Xinbang Pharmaceutical Co., Ltd.'s 2021 continuous supervision and regular on-site inspection report CFi.CN Zhongcai.com

SINBON PHARMACEUTICAL (002390): Announcement on Expected Daily Connected Transactions in 2022- CFi.CN Zhongcai Network

Xinbang Pharmaceutical (002390): Internal Control Self-Assessment Report CFi.CN

Xinbang Pharmaceutical (002390): Internal Control Assurance Report CFi.CN

Xinbang Pharmaceutical (002390): Minsheng Securities Co., Ltd.'s special verification opinion on the storage and use of funds raised by Guizhou Xinbang Pharmaceutical Co., Ltd. through non-public offering of stocks in 2021- CFi.CN Zhongcai Network

Want to see more data? Registered subscribers can see all the data.